# HCC Screening Using DNA Methylation Changes in ctDNA

> **NCT03483922** · — · COMPLETED · sponsor: **HKGepitherapeutics** · enrollment: 403 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** ctDNA methylation in and it's Correlation wth Development and prediction of HCC

## Key facts

- **NCT ID:** NCT03483922
- **Lead sponsor:** HKGepitherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-20
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-11-01
- **Target enrollment:** 403 (ACTUAL)
- **Last updated:** 2024-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483922, "HCC Screening Using DNA Methylation Changes in ctDNA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03483922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*